AIRZ F DIGIHALER

Description

Airz F DigiHaler is a digital dry powder inhaler (DPI) designed for the treatment of asthma and COPD. The device is pre-loaded with a combination of two active ingredients:

• Fluticasone Furoate (a corticosteroid) helps reduce airway inflammation, mucus production, and swelling in the lungs.

• Vilanterol (a LABA) works by relaxing the muscles in the airways, improving airflow, and preventing airway constriction.

Key Features:

• Precise Dose Delivery: The DigiHaler ensures a consistent and accurate dose with every inhalation.

• Tracking Capability: The device can track usage and send reminders, making it easier for patients to adhere to their prescribed regimen.

• Compact and Easy-to-Use: The digital design ensures efficient drug delivery while providing real-time data to both patients and healthcare providers.

Indications:

• Asthma: For long-term control of asthma symptoms, including wheezing, coughing, and shortness of breath.

• COPD: For the management of chronic obstructive pulmonary disease symptoms, reducing flare-ups and improving quality of life.

How It Works:

• The Fluticasone Furoate component reduces inflammation, and the Vilanterol component helps keep the airways open by relaxing the muscles surrounding the airways.

• The DigiHaler provides the medication in a dry powder form, which is inhaled directly into the lungs for quick and efficient action.

Dosage:

• One inhalation per day, as prescribed by your healthcare provider.

Side Effects:

• Common side effects include headache, throat irritation, muscle cramps, or upper respiratory tract infections.

• Serious side effects may include increased heart rate, irregular heartbeats, or severe difficulty breathing.